Health & Medicine
- Life
DNA tweak no good for diabetics
A genetic variation that increases levels of a blood-building protein also ups the risk of developing complications from diabetes.
- Health & Medicine
Potential for protection
A study of U.S. veterans suggests that the anti-inflammatory drug ibuprofen could have a protective effect against Alzheimer’s disease. But researchers say more work is needed.
By Nathan Seppa - Health & Medicine
Rice Woes, Pt. 1
A shortfall in rice production has been developing well under the radar screen of agricultural economists and growers. The bad news: It promises to get much worse, and fairly soon.
By Janet Raloff - Earth
It’s the meat not the miles
Eating less red meat and dairy may do more to reduce food-associated greenhouse gas emissions than shopping locally.
- Health & Medicine
Treat ’em
High blood pressure often goes untreated in people 80 and over, but a new study suggests that treatment extends survival.
By Nathan Seppa - Health & Medicine
Mondo bizarro
Psychiatrists measuring the degree of similarity between dreams and psychotic ruminations report some strange features common to both.
By Amy Maxmen - Health & Medicine
Friend or foe? Drunk, the brain can’t tell
Intoxicated brains can’t discern between threatening and safe situations.
- Health & Medicine
Let there be light
Researchers report restoring vision to people with a rare, genetic form of blindness. A different technique helped blind mice see again and could bring back some sight in people with macular degeneration, retinitis pigmentosa or other blinding diseases.
- Health & Medicine
Tripping up avian flu
Developing an effective vaccine for avian flu has been difficult, but small rings of DNA that hinder virus replication could offer an alternative.
-
- Health & Medicine
Pockets of poor health
Life expectancy decreases in some locations
By Nathan Seppa - Health & Medicine
New approach might strike at the core of Alzheimer’s disease
By finding a way to stick an enzyme-inhibiting molecule to the membrane of a cell, scientists may have devised the framework for an Alzheimer’s drug.
By Nathan Seppa